Sign Up | Log In | What is SocialPicks?

The Stock Idea & Analysis Community

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

James Mitchell (Goldman Sachs)

Start Tracking James Mitchell (Goldman Sachs)

This is a Tracking Account | Tracked since 03/18/2008 [?] SocialPicks is not affiliated with James Mitchell (Goldman Sachs)

This is a partial compilation of James Mitchell (Goldman Sachs)'s posts and is not meant as a complete representation of the blogger's performance.

Overview

Stocks

Blogs

Stats

Community

James Mitchell (Goldman Sachs)'s Blog Posts

FMCN Stock Arguably Overreacting to TV Program on Push SMS 03/18/08 — 3/17 - "A China state TV channel aired a program last weekend covering (among other items) alleged “spamming” of (i.e., pushing SMS advertisements to) mobile phone customers by Focus Wireless." "1) Focus Wireless accounted for 9% of Focus’ revenue last quarter and, we assume, a similar porti...

Read 0 comments

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.44%	381
2	Gerald Greene	18.14	+71.24%	211
3	stockmarketfunding.com	17.66	+25.60%	55
4	akiralegrand	13.47	+14.32%	62
5	anup2104	12.13	+74.22%	40

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
MSFT	Microsoft Corp
NVDA	NVIDIA Corp
AMZN	Amazoncom Inc
XOM	Exxon Mobil Corp
YHOO	Yahoo! Inc
BIDU	Baiducom Inc ADS

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

DNDN		Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ: D... by Mike Havrilla
CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev

... more »

More about James Mitchell (Goldman Sachs)

Avg exp holding time:
627.00 days

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.